Ozempic was launched in India on Friday (December 12). The blockbuster drug by Novo Nordisk will be marketed for adults with type-2 diabetes, unlike in the US and Europe where it is also sold as ...

Courtney Wood has vowed never to fly with Jet2 again after having to leave the plane due to type 1 diabetes ...

LOWELL — In response to several city councilor motions, City Solicitor Corey Williams presented an ordinance to the body at its Nov. 25 meeting that bans needle exchange programs, including sharps ...

For patients with diabetes, the days after hospital discharge can be as risky as the days leading up to admission. Clinicians ...

In 2024, Jessica Beck's battle with leukemia transformed when her brother's bone marrow donation offered hope amid life-threatening challenges.

The blockbuster diabetes and weight loss drug Ozempic has been launched in India. Novo Nordisk on Friday launched the once-weekly injectable formulation of semaglutide at a starting price of Rs 8,800 ...

Retatrutide, originally developed by Eli Lilly, has found a loyal fan base—even though clinical trials of the drug still ...

Diabetes is on the rise among individuals with intellectual and developmental disabilities, who face barriers to maintaining ...

Ozempic, the global blockbuster diabetes and weight-loss drug, is finally in India. Novo Nordisk India launched the hugely ...

On a cold December afternoon, the Winnipeg Y Service Club Christmas tree lot in East Kildonan is filled with balsam fir and Manitoba spruce trees. The 100-per cent-volunteer-run tree sale puts all its ...

VANCOUVER, BC / ACCESS Newswire / December 11, 2025 / LIR Life Sciences Corp. (CSE:SKNY)(Frankfurt:N790, WKN: A41QA9) ("LIR" or the "Company") announces that it has filed a provisional patent ...

Novo Nordisk, the Denmark based pharma giant, has finally launched its hugely popular diabetes and weight-loss medicine, Ozempic, in the Indian market. Ozempic has recently garnered global recognition ...